About US
Contact us
-
Too many kids poisoned with prescription drugs: StudyBy Dr Ananya Mandal, MD Figures show that each year half a million kids age 5 and younger get into household medications and are poisoned. Though parents tend to believe that these tragic accidents2011/9/20
-
Safety tips to prevent unintentional pediatric medication poisoningsA study discussing the dramatic increase in the number of children being poisoned by unintentionally ingesting medications was published online today in the Journal of Pediatrics. This study shows tha2011/9/19
-
New paper describes unique process that is central to induction of MSRA antibiotic resistanceA new paper by a team of University of Notre Dame researchers that included Shahriar Mobashery, Jeffrey Peng, Brian Baker and their researchers Oleg Borbulevych, Malika Kumararasiri, Brian Wilson, Let2011/9/16
-
New study aims to reduce number of pediatric pharmaceutical poisoningPharmaceutical poisoning remains a common childhood injury, despite years of concerted prevention efforts, such as improved safe guards on packaging. Over half a million children are exposed to phar2011/9/16
-
Researchers discover several chemical compounds against human prion diseasesFinding opens possibility of treating brain-wasting mad cow disease In a new study NYU School of Medicine researchers report that they have found several chemical compounds, including an antidepressa2011/9/15
-
Reminder packaging improves adherence to long-term hypertension medicationsPeople with chronic illnesses are more likely to take long-term medications according to doctors' instructions if the packaging includes a reminder system, according to a new review of evidence. Re2011/9/14
-
Merck and BGI forge genomic biomarker allianceMerck has teamed up with BGI, the world's largest genomics centre, to discover and develop of biomarkers and genomic technologies. Under the agreement, scientists from Merck and BGI will work toget2011/9/13
-
Sanofi CEO issues positive 2012 estimatesSanofi CEO Chris Viehbacher has told investors that the company expects growth in 2012 as it approaches the end of its 'patent cliff' and recent acquisitions begin to perform. Over the past three y2011/9/9
-
First-ever comprehensive study of species origins of nature-derived drugsIn a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting t2011/9/8
-
SFDA Deputy Commissioner Wu Zhen meets the Head of Iran's Innovation and Technology Cooperation CenterOn the morning of September 6, 2011, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Hamidreza Amirinia, Head of Innovation and Technology Coop2011/9/8